Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
The EXPO news page on Stock Titan aggregates recent press releases and market-moving updates related to Exponent, Inc., a science and engineering consulting firm listed on Nasdaq. Exponent reports regularly on its financial results, business trends across its engineering and other scientific segment and its environmental and health segment, and developments in the industries it serves. These updates often include commentary on dispute-related engagements, proactive risk management projects, and regulatory consulting work.
Investors following EXPO news can review quarterly earnings releases that discuss revenues before reimbursements, operating income, net income, and non-GAAP measures such as EBITDA and EBITDAS. Management commentary provides context on demand in sectors such as construction, automotive, medical devices, chemicals, transportation, utilities, life sciences, consumer electronics, and consumer products. Releases also describe how Exponent’s multidisciplinary teams address issues like failure analysis, asset integrity, digital health, artificial intelligence usability, and distributed energy systems.
In addition to earnings, Exponent’s news flow includes announcements about regular quarterly cash dividends and share repurchase authorizations. The company has reported dividend declarations for multiple quarters and increases to its stock repurchase program, offering insight into its capital allocation approach. Other items covered in EXPO news include scheduling and access details for quarterly conference calls and webcasts where executives discuss business performance and outlook.
By monitoring the EXPO news page, readers can track how Exponent’s two operating segments perform over time, how demand is evolving across the industries it serves, and how the company uses dividends and repurchases alongside investment in talent and capabilities. This page is a convenient way to review Exponent’s official communications and financial updates in one place.
Exponent, Inc. (Nasdaq: EXPO) reported Q3 2022 financial results, showing a 9.3% increase in total revenues to $127.2 million year-over-year, with EBITDA at $34.6 million, representing 30.0% of revenues. However, net income slightly decreased to $24.4 million or $0.47 per diluted share. Year-to-date revenues grew 9.4% to $385.9 million, but net income fell to $79.8 million. Looking ahead, Exponent anticipates mid- to high-single-digit revenue growth for Q4 and a 6-7% growth for the full year, though EBITDA margins are expected to decrease by 100 to 125 basis points.
Exponent, Inc. (Nasdaq:EXPO) will announce its third-quarter financial results for the fiscal year 2022 on October 27, 2022, after market close. A conference call hosted by CEO Dr. Catherine Corrigan and CFO Richard Schlenker will follow at 4:30 p.m. ET. Investors can access the call via phone or through a webcast on the company’s website. Exponent specializes in engineering and scientific consulting, utilizing over 50 years of experience to address complex challenges across various technical disciplines.
Exponent, Inc. (Nasdaq: EXPO) reported Q2 2022 revenues of $130.3 million, up 8.7% year-over-year, with net income at $25.8 million or $0.49 per diluted share. Year-to-date revenue rose 9.5% to $258.8 million, but net income dropped to $55.4 million, or $1.05 per diluted share. The company anticipates mid-single-digit revenue growth for Q3 and maintains its annual revenue guidance while lowering its EBITDA margin outlook. Exponent's cash and equivalents stand at $165.6 million, and it has a share repurchase authorization of $106.6 million left.
Exponent, Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.24 per share, payable on September 23, 2022, to stockholders of record as of September 9, 2022. The company has a history of quarterly dividends paid in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized this move reflects confidence in Exponent's business strength and commitment to shareholder value. Exponent specializes in complex problem-solving across various technical disciplines, leveraging over 50 years of experience to serve clients effectively.
Exponent, Inc. (Nasdaq:EXPO) announced that its Q2 fiscal year 2022 financial results will be disclosed post-market on July 28, 2022. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results, featuring Dr. Catherine Corrigan and Richard Schlenker. A telephonic replay will be available until August 4, 2022. Exponent is recognized for its interdisciplinary consulting services, offering solutions across over 90 technical disciplines and leveraging 50 years of experience in complex problem-solving.
Exponent, Inc. (Nasdaq:EXPO) announced that Dr. Catherine Corrigan and Richard Schlenker will present at two upcoming investor conferences. The Berenberg Conference USA 2022 is scheduled for May 25, 2022, from 10:15am to 11:00am ET, followed by the Stifel Cross Sector Insight Conference 2022 on June 8, 2022, from 1:15pm to 1:45pm ET. A webcast of the presentations will be available on Exponent’s investor relations page, with an archived replay accessible afterward.
Exponent, Inc. (Nasdaq: EXPO) announced a quarterly cash dividend of $0.24 per share, payable on June 24, 2022, to stockholders of record as of June 10, 2022. The firm confirmed its commitment to continuing quarterly dividends each year in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, noted that this dividend reflects the strength of the company's balance sheet and business model, aimed at generating long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported a 10.3% increase in total revenues for Q1 2022, reaching $128.5 million year-over-year, alongside a decrease in net income to $29.6 million or $0.56 per diluted share. EBITDA grew to $34.5 million, representing 29.2% of net revenues. The company anticipates mid-single digit growth for Q2 revenues and mid- to high-single digit growth for the full year 2022. Exponent continues to focus on expanding its engineering and scientific services across various sectors, particularly in consumer electronics and life sciences.
Exponent, Inc. (Nasdaq:EXPO) will announce its first quarter of fiscal year 2022 financial results on April 28, 2022, after market close. The conference call will begin at 4:30 p.m. ET, featuring CEO Dr. Catherine Corrigan and CFO Richard Schlenker. Investors can join the call via phone or through a live webcast available on the company’s investor relations site. Exponent specializes in engineering and scientific consulting, leveraging over 50 years of experience to provide solutions across 90 technical disciplines.
Exponent, Inc. (Nasdaq: EXPO) announced a $150 million expansion of its share repurchase program, increasing total available repurchases to approximately $179.5 million. The firm has repurchased $38.9 million of common stock in fiscal year 2022. CEO Dr. Catherine Corrigan expressed confidence in Exponent’s strategic direction and commitment to delivering shareholder value, noting a recent 20% increase in the quarterly dividend. Exponent ended fiscal 2021 with $297.7 million in cash and cash equivalents, supporting its robust capital allocation strategy.